Butanilicaine

CAS : 3785-21-5

Ref. 3D-FB148400

Informations sur le produit

• Nom: Butanilicaine
• Synonymes: 1-(Butylaminoacetylamino)-2-chloro-6-methylbenzene, 2-(Butylamino)-6′-chloro-o-acetoluidide, 2-(Butylamino)-N-(2-chloro-6-methylphenyl)acetamide, 2-Butylamino-6-Chloroacet-O-Toluidide, 2-Butylamino-6′-chloro-o-acetotoluidide, Acetamide, 2-(butylamino)-N-(2-chloro-6-methylphenyl)-, N~2~-butyl-N-(2-chloro-6-methylphenyl)glycinamide, o-Acetotoluidide, 2-(butylamino)-6′-chloro-, ω-n-Butylaminoacetic acid 2-methyl-6-chloroanilide

Description

Butanilicaine is a hydrogen tartrate, which is a drug that has been studied for its potential use in the treatment of autoimmune diseases. It also has synergistic effects with other drugs and can be used to treat infectious diseases. Butanilicaine has been shown to inhibit the production of angiogenic factors and amide adenine nucleotide (AMP) levels in rat liver microsomes. Studies have also shown that butanilicaine may be useful in the treatment of metabolic disorders, such as those caused by nonsteroidal anti-inflammatory drugs.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 254.76 g/mol
• Formule: C₁₃H₁₉ClN₂O
• Degré de pureté: Min. 95 Area-%
• Couleur/Forme: Powder
• InChI: InChI=1S/C13H19ClN2O/c1-3-4-8-15-9-12(17)16-13-10(2)6-5-7-11(13)14/h5-7,15H,3-4,8-9H2,1-2H3,(H,16,17)
• Code InChI: InChIKey=VWYQKFLLGRBICZ-UHFFFAOYSA-N
• SMILES: CCCCNCC(=O)Nc1c(C)cccc1Cl